- Product Enquiry
- Additional information
- Reviews (0)
Velasof is Combination of Velpatasvir 100mg with Sofosbuvir 400mg. Velpatasvir 100mg with Sofosbuvir 400mg is a two-drug mix for the treatment of hepatitis C contamination which stops the development of infection in the blood. Sofosbuvir With Velpatasvir is a two-medicine blend for the treatment of hepatitis C. Each and the everyday pill containing the viral NS5A inhibitor velpatasvir and sofosbuvir, a nucleotide inhibitor of the viral RNA polymerase. It is the main treatment, that works for all genotypic, and is taken altogether by mouth. A solitary tablet regimen is utilized for grown-ups with genotype 1-6 interminable hepatitis C infection (HCV) disease.
Sofosbuvir With Velpatasvir is accessible as a co-formulated, once-everyday single-pill blend of sofosbuvir 400 mg and velpatasvir 100 mg. The suggested measurements is one tablet once day by day, taken with or without nourishment.
For patients with gentle to direct renal hindrance, no dose modification of sofosbuvir-velpatasvir is prescribed. There are lacking information in regards to the wellbeing and adequacy of sofosbuvir-velpatasvir in patients with extreme renal impedance or end-organize renal illness requiring hemodialysis. In like manner, no measurement proposal has been given for patients with serious renal weakness or end-arrange renal sickness requiring dialysis.
For patients with mellow, direct, or serious hepatic disability (Child-Pugh Class A, B, or C), no measurement alteration for sofosbuvir-velpatasvir is suggested. For patients with decompensated cirrhosis who are getting sofosbuvir-velpatasvir and ribavirin, clinical and research center checking is prescribed.
- Feeling Tragic Or Exhaust
- Need Or Loss Of Quality
- Loss Of Intrigue Or Joy
- For Healthcare Professionals
Enquiry about Velasof